Alpine Immune Sciences raising $17M in advance of merger with Colorado pharmaceutical company by Monica Nickelsburg on April 19, 2017April 19, 2017 at 1:41 pm Seattle biotech company Alpine Immune Sciences isĀ raising $17 million as part of a merger with Nivalis, a publicly-traded pharmaceutical firm inĀ Boulder, Colo. Frazier Healthcare Partners, Alpine BioVentures, and OrbiMed Advisors… Read More